• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Insulet promotes COO to corner office as CEO Sullivan sets retirement date

September 11, 2018 By Sarah Faulkner

Insulet omnipodInsulet (NSDQ:PODD) announced this week that president & COO Shacey Petrovic will succeed CEO Patrick Sullivan after he retires at the end of the year. Petrovic plans to stay on as president of the Billerica, Mass.-based company.

Sullivan will retire from Insulet’s board effective Jan. 1, 2019 and will hold a consulting role with the company through the end of 2019. Board-member Timothy Scannell will become chairman effective Jan. 1, 2019.

Petrovic first joined Insulet in Feb. 2015, serving as the company’s chief commercial officer. Since then, she has moved on to work as its president & COO, leading the company’s day-to-day operations.

Sullivan joined Insulet in 2014, with an established history in the medical device industry. From 1994 to 2007, he was chairman, president & CEO of Cytyc, which was later acquired by Hologic. There, he served as executive chairman of the women’s health company. He also serves as a director on the board of PerkinElmer.

“It has been a great privilege to lead Insulet over the past four years, and I am proud of what we have accomplished and how well-positioned Insulet is for continued success,” Sullivan said in prepared remarks. “We have achieved a great deal and the company is on a very positive growth trajectory. We have deliberately and thoughtfully planned for this succession and I am confident it’s the right time to transition the company to its next generation of leadership. Shacey has made a tremendous impact since joining Insulet and her insights and experience will be instrumental to take the company forward as a global leader in diabetes.”

“Pat has done an outstanding job establishing Insulet’s leadership within the industry and positioning the company for continued growth. I have learned a tremendous amount from his mentorship and I appreciate his strong example of dedication, discipline and strategic vision. This is a time of incredible opportunity for Insulet, and I am focused on building on our significant momentum to drive growth and continued value creation. It will be a privilege to lead this company, and I look forward to working with the entire Insulet team to achieve our strategic and financial objectives while furthering our mission to improve the lives of people with diabetes,” Petrovic added.

Analysts were pleased with the announcement. Danielle Antalffy, Rebecca Wang and Dylan Gantley of Leerink wrote that the transition “indicates that PODD fundamentals are stronger than ever and will now be in the hands of Petrovic – someone who’s proven to be very capable at managing the business.”

Want to stay on top of DDBN content? Sign up for our e-mail newsletter for a weekly dose of drug-device news.

Filed Under: Diabetes, Drug-Device Combinations, Featured, Wall Street Beat Tagged With: Insulet

IN CASE YOU MISSED IT

  • Dexcom updates CGM receiver recall that led to serious adverse events
  • Abbott reports momentum with Libre CGM business as new dual sensor will ‘accelerate’ growth
  • Johnson & Johnson wins FDA priority review for drug delivery system
  • Glucose monitoring company LifeScan files chapter 11 to reduce debt
  • Medtronic enrolls first patient in study for Onyx liquid embolic system

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS